Background Polygenic risk scores (PRSs) have successfully summarized genome-wide effects
of genetic variants in schizophrenia with significant predictive power. In a clinical sample …

A primary goal of polygenic scores, which aggregate the effects of thousands of trait-associated
DNA variants discovered in genome-wide association studies (GWASs), is to estimate …

The recent SARS-CoV-2 pandemic manifests itself as a mild respiratory tract infection in most
individuals, leading to COVID-19 disease. However, in some infected individuals, this can …

The Developing Human Connectome Project has created a large open science resource
which provides researchers with data for investigating typical and atypical brain development …

The decreasing cost of performing genome-wide association studies has made genomics
widely accessible. However, there is a paucity of guidance for best practice in conducting such …

Background: Microarray technologies have identified imbalances in the expression of specific
genes and biological pathways in Alzheimer’s disease (AD) brains. However, there is a …

Individuals with intact cognition and neuropathology consistent with Alzheimer’s disease (AD)
are referred to as asymptomatic AD (AsymAD). These individuals are highly likely to …

We used a case–control genome-wide association (GWA) design with cases consisting of
1238 individuals from the top 0.0003 (~ 170 mean IQ) of the population distribution of …

Cytochrome (CYP) P450 enzymes have a primary role in antidepressant metabolism and
variants in these polymorphic genes are targets for pharmacogenetic investigation. This is the …

Background Major depressive disorder (MDD) has a high personal and socio-economic
burden and > 60% of patients fail to achieve remission with the first antidepressant. The …